Skip to main content
OpenTrials

Clinical trial condition

Influenza

Explore clinical trials studying Influenza. Study availability and eligibility vary by location and protocol.

1,218 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Influenza trial results

Completed

Study to Evaluate Immunogenicity and Safety of a High-Dose Influenza Vaccine in Adults 50 Through 64 Years of Age

NCT06641180

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • CenExel CNS- Site Number : 8400005 Los Alamitos, California, United States
  • Alliance for Multispeciality Research - Fort Myers- Site Number : 8400019 Fort Myers, Florida, United States
  • Research Centers of America - Hollywood- Site Number : 8400010 Hollywood, Florida, United States
  • IACT Health - Columbus - Talbotton Road- Site Number : 8400011 Columbus, Georgia, United States
View all 20 locations
View Trial Details
Completed

Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 Vaccine (SARS-CoV-2 [COVID-19] and Influenza) in Adults ≥50 Years of Age

NCT06694389

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +12 more
Locations
  • Public Health Association.Inc. Nagoya, Aichi-ken, Japan
  • Daido Clinic Nagoya, Aichi-ken, Japan
  • Tenjin Sogo Clinic Fukuoka, Japan
  • PS Clinic - Internal medicine Fukuoka, Japan
View all 44 locations
View Trial Details
Completed

Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection

NCT00800605

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • Quality of Life Medical & Research Center, LLC Tucson, Arizona, United States
  • Benchmark Research Sacramento, California, United States
  • California Research Foundation San Diego, California, United States
  • Benchmark Research San Francisco San Francisco, California, United States
View all 36 locations
View Trial Details
Completed

A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age

NCT06864143

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +13 more
Locations
  • Headlands Research Scottsdale Scottsdale, Arizona, United States
  • Artemis Research (Headlands) San Diego, California, United States
  • Clinical Research Atlanta (Headlands) Stockbridge, Georgia, United States
  • Velocity Clinical Research, Boise Meridian, Idaho, United States
View all 17 locations
View Trial Details
Completed

Flublok or Fluzone With Advax-CpG55.2 or AF03

NCT03945825

Conditions
Infections, Influenza, Influenza Immunisation, +6 more
Locations
  • Emory University School of Medicine Atlanta, Georgia, United States
  • University of Iowa - Vaccine Research and Education Unit Iowa City, Iowa, United States
  • University of Maryland Baltimore - School of Medicine - Medicine Baltimore, Maryland, United States
  • Saint Louis University Center for Vaccine Development St Louis, Missouri, United States
View Trial Details
Completed

A Clinical Study to Investigate the Safety and Immunogenicity in Relation to Product Attributes of mRNA-1083 (Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2] and Influenza Vaccine)

NCT06508320

Conditions
Infections, Influenza, Influenza, Human, +6 more
Locations
  • Indago Research & Health Center, Inc. Hialeah, Florida, United States
  • Cenexel RCA Hollywood, Florida, United States
  • Suncoast Research Group, LLC DBA Flourish Research Miami, Florida, United States
  • Cenexel IRA Decatur, Georgia, United States
View all 17 locations
View Trial Details

Related conditions